clinics. 16 Concerns about invasive testing, such as swabs or examinations, also impede testing. 17 Similarly, being asked one's sexual health history (i.e., when clinicians ask about sexual contacts) makes some persons, primarily sexual minorities, less willing to undergo testing. 18, 19 Other barriers relate to health care provider behaviour, such as judgemental attitudes or limited knowledge -for instance, when clinicians do not offer HIV testing when persons, particularly sexuallyactive MSM, present for care with HIV seroconversion symptoms (e.g., rash, fever, fatigue, flu-like symptoms). 20, 21 Researchers have further identified that gender norms of masculinity affect testing. 17, 19 For men to undergo testing, they must reject norms about masculinity, which dictate that they should be autonomous and invulnerable. 17 Often during testing, however, men follow a clinician's direction, and by simply accessing testing, must admit that they could have an infection and thus that they are vulnerable. Taken as a whole, therefore, the reasons people do not access STI/HIV testing are 1) a lack of desire to do so (whether this relates to lack of concern, feelings of immunity, or incomplete understandings) and/or 2) an inability to obtain the STI/HIV testing they seek.
Reasons for Accessing an STI/HIV Clinic
Researchers have also explored why people attend STI/HIV clinics. Rationales included: same-day access through walk-in services; perceived comprehensiveness of testing and specialized knowledge; desires not to discuss sexual practices with general practitioners (GPs); availability of anonymous or point-of-care testing; and referral, e.g., for a second opinion or specialized treatment. [22] [23] [24] In one study, obtaining testing for all STIs/HIV (comprehensiveness) and perceived specialized knowledge at STI clinics resulted in some persons who first sought care with their GPs subsequently visiting STI/HIV clinics to obtain the testing they felt their GPs missed. 25 In this study, STI/HIV testing with GPs resulted in duplicate service utilization. Thus, although certain factors undermine people's willingness to access STI/HIV clinics, these services have attributes that nevertheless entice attendance.
Participants and intervention: The GayZone Clinic
In September 2008, Ottawa Public Health established GayZone, which is an STI/HIV testing clinic for MSM at Centretown Community Health Centre. While health promotion activitiesfairs, cooking clubs, yoga -are ongoing aspects of GayZone, this report focuses solely on the clinic, which is open three hours/week on Thursday evenings, and typically has, per shift, two physicians, one nurse practitioner, three registered nurses and one outreach worker. These staff offer free-of-charge: STI/HIV testing † , STI treatment (gonorrhea, chlamydia, syphilis, genital herpes and warts), vaccination for hepatitis A/B, HIV post-exposure prophylaxis (PEP), counselling about STIs/HIV and their prevention, and condoms. Patients who attend GayZone are offered STI/HIV testing as warranted based on sexual history and symptoms.
In terms of clinic flow, patients indicate on a self-directed intake form the services they want and whether or not they have symptoms. Patients who request PEP are assessed immediately. All others are seen on a first-come-first-served basis by one clinician who provides all care. Physicians and nurse practitioners assess patients who report symptoms; nurses screen self-identified asymptomatic patients (under medical directives) and refer patients to the physicians or nurse practitioner as warranted (e.g., when signs are identified). The outreach worker performs anonymous ‡ point-of-care HIV testing.
For follow-up of name-based testing, a clinic nurse contacts patients within 2-3 weeks as required (e.g., if a result is identified in the laboratory as positive or contaminated). Such follow-up occurs first by phone and then by e-mail or text message, if clients consent. For STIs, all treatment is done at GayZone, and for HIV, referral to local HIV care physicians is arranged. For anonymous testing, when point-of-care HIV test results are non-reactive and serology is not performed, follow-up is not required. The client receives the nonreactive result immediately and is discharged. In the event of serological specimen collection (e.g., as a client's preferred testing strategy or to confirm a reactive point-of-care test result by Western blot), clients receive a code that identifies their specimen, and are instructed to return to the clinic with this code after three weeks to obtain their test result. Failure on the client's part to produce this code at the three-week follow-up visit precludes disclosure of test results.
RESULTS
The Finally, the gonorrhea and chlamydia pharyngeal swabs identified 5 infections from 3,757 tests (0.13% positivity rate). There was 1 case of pharyngeal gonorrhea from 1,876 tests and 4 cases of pharyngeal chlamydia from 1,881 tests. Four of these cases (all chlamydia) had a positive urine (n=2) and/or rectal swab (n=3) result, reducing the number of unique diagnoses from pharyngeal swabs to 1 (0.02% positivity rate). For the rectal swabs, there were 5 cases of rectal gonorrhea from 1,202 tests and 34 cases of rectal chlamydia from 1,242 tests, yielding 39 (1.6%) diagnoses from 2,444 tests. The urine testing identified 18 cases of gonorrhea from 2,125 tests and 53 cases of chlamydia from 2,130 tests, for a total of 71 (1.67%) cases from 4,255 tests.
DISCUSSION
Regarding our objectives of 1) creating a culturally sensitive STI/HIV testing site for MSM and 2) decreasing STI/HIV transmission by reducing the period of infectivity, our data suggest we were partially correct in our hypotheses. For objective 1, the usage numbers indicated an increase in both the uptake and proportion of patients undergoing repeat testing, which suggests, as previous research with men from GayZone identified, 24 that this clinic is well liked by MSM. Further supporting that GayZone is well used are the public health laboratory figures from 2011 (most recent available), 26 GayZone patients have GPs, led us to believe that some MSM may simply prefer accessing STI/HIV testing at GayZone, thus satisfying objective 1. The limitations of our data (in that they do not directly measure this outcome), however, highlight the need for future research on this topic. For objective 2 (reducing incidence), our data were less clear. Although infections were identified among asymptomatic patients, thus reducing forward transmission in these instances, we are unsure if this process was sufficient to actually affect STI/HIV transmission at the community level. Suggesting that GayZone may have influenced community-level transmission were the data showing that, between 2011-2013, an average of 12.6% of all HIV diagnoses in Ottawa occurred at this clinic. If one uses the historical figures that 50-60% of HIV diagnoses in Ottawa occur among MSM, 2, 4, 26 then GayZone is the location for approximately 22-25% of all HIV diagnoses among MSM during 2011-2013. As far as we know, no other testing initiatives have produced similar yields in Ottawa. Likewise, the positivity rate for urine gonorrhea testing at GayZone in 2013 (1.6%) was over double that of urine and cervical gonorrhea testing in the community and at the city's main STI clinic (0.6-0.81%).
However, other positivity rates indicate that GayZone may not have affected STI/HIV transmission at the community level as much as had been hoped for. For example, in 2011, the GayZone positivity rate for nominal HIV tests (0.9%) virtually matched the rate among MSM across Ottawa (0.89%). Because the estimated HIV prevalence rate among MSM in Ottawa is greater than 10%, 4,5 with roughly 20% of these men unaware they are HIV-positive, 2 one would reasonably expect higher positivity rates at our clinic than were observed. Further undermining the possible community-level effect that GayZone could have had was that approximately 75-78% of HIV diagnoses among MSM in Ottawa occurred elsewhere. Similarly, notwithstanding that, in 2010, 91% of infectious syphilis diagnoses involved MSM, only an approximate 30% of these infections were diagnosed at GayZone from 2011 to 2013.
Such unremarkable, albeit important, diagnosis outcomes led us to believe that GayZone attendance may have been low among MSM who are most susceptible to STIs/HIV; i.e., MSM who primarily engage in unprotected sex, yet infrequently undergo testing. The majority of GayZone patients, in contrast, reported condom use, and many underwent STI/HIV testing more than once per year. Thus, although testing could reduce duration of infectivity and STI/HIV incidence, 7, 8 recurrent testing among a small cohort of MSM who often use condoms may limit GayZone's effectiveness as a community-level prevention initiative. Widespread testing among larger groups of MSM might be required to substantially reduce the duration of infectivity and STI/HIV incidence. Specifically, efforts need to be made to maintain current testing strategies among the men who visit GayZone, while also expanding uptake to other men, including men previously diagnosed with HIV and men who are less attached to the gay community and/or gay identity (i.e., straight-identifying MSM). This is not to say that GayZone was ineffective; many diagnoses did occur, and the percentage of undiagnosed HIV infections (i.e., 0.7-1.8%) was higher than the Centers for Disease Control screening threshold of 0.1%. 27 Simply, the number of diagnoses at GayZone was not as high as we hypothesized it would be based on available incidence and prevalence data. Nevertheless, an important consideration is that GayZone only operates 3 hours per week. Because limited hours constrain attendance, it is possible that GayZone's ability to affect STI/HIV incidence at the community level may be restricted by time and service availability. 8 
Recommendations
First, we believe that anonymous HIV testing should be maintained. Seventy-five percent of HIV diagnoses at GayZone during 2011-2013 were among persons who chose anonymous testing, demonstrating the utility of this testing modality. However, because people cannot easily access HIV treatment anonymously, since treatment is typically linked with patient names, it may be worthwhile to consider revising access-to-care stipulations for HIV treatment, at least for the period immediately following diagnosis. If the goals of HIV testing are to improve health outcomes for persons living with HIV and to decrease transmission, and anonymous testing corresponds with such outcomes, should we not scale up and facilitate access to such services? 3, 4 Second, the low yield of our pharyngeal swabs warrants reflection. Only one additional chlamydia infection was identified from 3,757 tests, which must be considered in the light of the time taken to complete these tests and the fact that people leave GayZone without being seen due to increasing wait-times. While researchers 28 have reported higher rates of pharyngeal infection than we identified, these other studies relied on nucleic acid amplification testing (NAAT). Our results, which report on the findings of standard clinical practice that uses culture-based testing for extra-genital specimens -the only method currently available in most jurisdictions in Canada -suggest that this testing may not be worthwhile when performed using culture media. Accordingly, efforts should be made to expand the use of NAAT for extra-genital testing for gonorrhea and chlamydia. In the meantime, researchers should identify clinical indicators that predict the need for culturebased pharyngeal testing.
Third, efforts should be made to ensure that sexually active HIVdiagnosed MSM are informed about STI testing. If the estimated HIV prevalence rate among MSM in Ottawa exceeds 10%, 4,5 and only roughly 4.0% of GayZone patients were HIV-positive, one must question why this proportion was so low. While some HIVpositive MSM may not be sexually active, and others may undergo testing with their HIV care providers, it is important to address STIs among these men; STIs can both compromise the health status of HIV-positive MSM and exacerbate HIV transmission. 29 Within the Anderson-May equation, 9 this could modify the probability of transmission (β) and thus should be a priority area for intervention. Further, researchers should establish if and where HIV-diagnosed MSM want to seek and obtain STI testing, or if initiatives are needed to develop and promote specialized clinics, such as GayZone.
Fourth, to expand access to persons not currently attending GayZone, clinic capacity should likely increase by a) developing a novel STI/HIV testing approach, in which asymptomatic patients, who are neither STI cases nor contacts, could undergo testing without providing sexual histories, and b) creating additional clinic time on a different day. The availability of testing without historytaking could allow GayZone to not only accommodate more patients but also provide a testing option for persons who do not access testing due to concerns about having to provide and/or discuss their sexual histories. Based on the extant literature, we e392 REVUE CANADIENNE DE SANTÉ PUBLIQUE • VOL. 105, NO. 5 speculate that some men avoid testing because they believe that clinicians will not view their sexual choices in an approving light. We would further hypothesize that if these men knew there would be no questions or judgement, they might be more inclined to seek testing. While there may be a lost opportunity for counselling, there would be an increased opportunity for STI/HIV diagnosis and thus for reducing transmission according to the equation. This would represent a substantial improvement as currently neither counselling nor testing occurs when such men outright avoid STI/HIV testing services. Meanwhile, a second clinic at a different time and on a different day could permit access to care for persons who are so inclined.
CONCLUSION
Based on the Anderson-May equation, 9 it is possible that STI/HIV testing can reduce transmission of these infections as a result of treatment and the behaviour changes that typically occur after diagnosis; i.e., by shortening the period of infectivity. 7, 8, 10 This process could, therefore, improve the health status of both persons and communities. However, testing will not induce such outcomes if infections are not identified. We thus believe that positivity rates and diagnostic yield || are appropriate measures for evaluating STI/HIV clinics. If positivity rates and diagnostic yields are poor in relation to local epidemiological data, consideration must be made about why this occurs, including a review to identify unforeseen barriers to testing.
In relation to GayZone, local data indicate that MSM are an appropriate priority population for STI/HIV services, but that the clinic's diagnostic yields require refinement; e.g., expanded service delivery, the delivery of NAAT-based pharyngeal swabs, and the identification of ways to serve diverse groups of MSM. In the absence of such changes, we suspect that the number of diagnoses at GayZone will continue to be more than adequate in relation to general STI/HIV screening guidelines (and thus warranting continuation of services), but unremarkable in relation to estimated population STI/HIV prevalence figures (and thus insufficient to decrease STI/HIV transmission among MSM). Service delivery changes are, therefore, warranted, and we encourage STI/HIV prevention workers, irrespective of role, to consider such findings when implementing new testing initiatives. 
RÉSULTATS :
La Zone gaie est une clinique abondamment utilisée qui établit chaque année un bon nombre de diagnostics d'ITS et de VIH. La proportion de tests de dépistage positifs y est au-dessus de la moyenne, bien qu'inférieure à ce que l'on pourrait attendre selon les données épidémiologiques locales. Le travail de la clinique a mis en lumière l'importance du dépistage anonyme du VIH, mais nous amène par ailleurs à nous interroger sur la pertinence des prélèvements pharyngés pour dépister la gonorrhée et la chlamydia.
CONCLUSION :
Non seulement les résultats obtenus témoignent-ils de l'utilité d'une clinique semblable, mais ils font également ressortir quelques points à améliorer. Les praticiens en santé publique, les cliniciens de première ligne et les travailleurs communautaires qui envisagent l'établissement d'une telle clinique spécialisée dans leur région seraient bien avisés de prendre d'abord connaissance des résultats de notre travail. 
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